COMPANY OVERVIEW

Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for the treatment of severe genetic diseases.

---

LOCATION

Bedford, MA, USA

---

THERAPEUTIC AREAS

Hematology

Liver Disease

Neurological Disorders

Ophthalmology

---

WEBSITE

https://www.stoketherapeutics.com

---

CAREER WEBSITE

https://www.stoketherapeutics.com/#careers

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Jun 21, 2019

Stoke Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Jun 18, 2019

Stoke Therapeutics Announces Pricing of Initial Public Offering

Jun 14, 2019

Stoke Therapeutics Appoints Jennifer Burstein to its Board of Directors

Mar 19, 2019

Stoke Therapeutics Appoints Industry Veteran Stephen Tulipano as Chief Financial Officer

Mar 7, 2019

Stoke Therapeutics to Present on First Disease-Modifying Therapies for Genetic Epilepsies at Cowen and Company Annual Health Care Conference

For More Press Releases

---